Abdurasid, Baby Boy .

HRN: 25-85-80  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
AMPICILLIN 500MG (VIAL)
09/11/2024
09/17/2024
IVTT
135mg
Q12h
Neonatal Sepsis
Waiting Final Action 
09/11/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
09/11/2024
09/17/2024
IVTT
13mg
Q24h
Neonatal Sepsis
Waiting Final Action 
09/12/2024
CEFOTAXIME 500MG (VIAL)
09/12/2024
09/18/2024
IVTT
135mg
Q12h
Neonatal Sepsis
Waiting Final Action 
09/19/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/19/2024
09/26/2024
IV
40mg
Q24h
Neonatal Sepsis
Waiting Final Action 
09/19/2024
CEFTAZIDIME 1GM (VIAL)
09/19/2024
09/26/2024
IV
140mg
Q12h
Neonatal Sepsis
Waiting Final Action 
09/22/2024
MUPIROCIN 2%, 15G (TUBE)
09/22/2024
09/28/2024
TOPICAL
Pea Size
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: